PhRMA Expects Study Results Database To Be Fully Populated By October
Executive Summary
The Pharmaceutical Research & Manufacturers of America expects full participation from all association members in the PhRMA-sponsored database ClinicalStudyResults.org by October
You may also be interested in...
Access To Vaccine Safety Data Is Different Than Trial Databases, NVAC Says
The Institute of Medicine's proposal to open the Vaccine Safety Database to independent research is "very different" than granting public access to registries of clinical trials, the National Vaccines Advisory Committee said
Study Result Disclosure Treated As Carefully As FDA Submissions – PhRMA
Drug companies are approaching their clinical trial results disclosures with the same degree of attention as FDA submissions, Pharmaceutical Research & Manufacturers of America VP-Scientific & Regulatory Affairs Caroline Loew said
Access To Vaccine Safety Data Is Different Than Trial Databases, NVAC Says
The Institute of Medicine's proposal to open the Vaccine Safety Database to independent research is "very different" than granting public access to registries of clinical trials, the National Vaccines Advisory Committee said